Joint Session EBMT - WBMT | Chimeric Antigen Receptor (CAR) T-cell and advanced cellular and gene therapies, minimizing disparities, regulatory issues and global collaboration to improve access

Mahmoud Aljurf, Ibrahim Yakub-Agha

Mickey Koh, Syed Osman Ahmed, Christian Chabannon

April 15, 2024

In this joint session of EBMT & WBMT, three experts across the globe gives comprehensive lectures on CAR T-cell and advanced cellular and gene therapies.
Dr Mickey Koh gives an overview on CAR-T and other gene therapies: Perspectives on worldwide access, affordability and clinical indications. Dr Syed Osman Ahmed follows with a topic on CAR T-cell and advanced cellular therapies, challenges and opportunities in emerging economies.
In the last talk, Dr Christian Chabannon focuses on the operational issues and procurement of the starting material for manufacturing of advanced therapies: a global challenge for hospitals and blood banks.

Don’t miss the short Q&A at the end of each lecture.


Presentations

CAR-T and other gene therapies: Perspectives on worldwide access, affordability and clinical indications - Mickey Koh

Chimeric Antigen Receptor (CAR) T-cell and advanced cellular therapies, challenges and opportunities in emerging economies - Syed Osman Ahmed

Procurement of the starting material for manufacturing of advanced therapies: a global challenge for hospitals and blood banks - Christian Chabannon